36
Participants
Start Date
July 1, 2019
Primary Completion Date
April 16, 2021
Study Completion Date
April 16, 2021
Placebo
Four-hour liquid mixed meal tests and a subsequent ad libitum meal during saline infusion.
GLP-1 antagonism
Four-hour liquid mixed meal tests and a subsequent ad libitum meal during exendin 9-39 and saline infusion.
GIP antagonism
Four-hour liquid mixed meal tests and a subsequent ad libitum meal during GIP(3-30) and saline infusion.
GLP-1 and GIP antagonism
Four-hour liquid mixed meal tests and a subsequent ad libitum meal during exendin and GIP(3-30) infusion.
Department of Endocrinology, Hvidovre
Hvidovre Hospital, Hvidovre
Hvidovre University Hospital
OTHER